BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 36288778)

  • 1. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
    Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
    Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
    van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
    J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of gut microbes and host's immune response in gut-lung homeostasis.
    Rastogi S; Mohanty S; Sharma S; Tripathi P
    Front Immunol; 2022; 13():954339. PubMed ID: 36275735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
    Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
    Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
    O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
    Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
    Kotlyarov S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
    Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.
    Tang Y; Du J; Wu H; Wang M; Liu S; Tao F
    Curr Neuropharmacol; 2024; 22(2):191-203. PubMed ID: 36173071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut-lung axis in severe acute Pancreatitis-associated lung injury: The protection by the gut microbiota through short-chain fatty acids.
    Wang Z; Liu J; Li F; Luo Y; Ge P; Zhang Y; Wen H; Yang Q; Ma S; Chen H
    Pharmacol Res; 2022 Aug; 182():106321. PubMed ID: 35752356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
    Duan H; Wang L; Huangfu M; Li H
    Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-chain fatty acid - A critical interfering factor for allergic diseases.
    Liu Y; Liu J; Du M; Yang H; Shi R; Shi Y; Zhang S; Zhao Y; Lan J
    Chem Biol Interact; 2023 Nov; 385():110739. PubMed ID: 37805176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbes, metabolites, and the gut-lung axis.
    Dang AT; Marsland BJ
    Mucosal Immunol; 2019 Jul; 12(4):843-850. PubMed ID: 30976087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
    Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acids of various lengths differentially inhibit
    Chang KC; Nagarajan N; Gan Y-H
    mSphere; 2024 Feb; 9(2):e0078123. PubMed ID: 38305176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury.
    Li Y; Zhang Y; Wei K; He J; Ding N; Hua J; Zhou T; Niu F; Zhou G; Shi T; Zhang L; Liu Y
    Front Cell Infect Microbiol; 2021; 11():577236. PubMed ID: 34307184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and comparison of short chain fatty acids composition in gut diseases.
    Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
    World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs.
    Machado MG; Sencio V; Trottein F
    Infect Immun; 2021 Aug; 89(9):e0018821. PubMed ID: 34097474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
    Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
    Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.